Panacos Pharmaceuticals, Inc. (NASDAQOTH:PANC)

CAPS Rating: No stars

A development stage biotechnology company that seeks to develop next generation anti-infective products through the discovery and development of small-molecule oral drugs designed to treat HIV and other major human viral diseases.

Recs

0
Player Avatar pennysplants (99.53) Submitted: 11/23/2012 12:15:21 PM : Outperform Start Price: $3.54 PANC Score: -92.47

Busted ! Cleaning up after 2 year hiatus from CAPS.

Featured Broker Partners


Advertisement